|
Kabra Drugs Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
46.09 Cr.
|
P/BV
|
1.87
|
Book Value (Rs.)
|
10.40
|
|
52 Week High/Low (Rs.)
|
23/10
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 7.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income From Operations | 7.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Traded Goods | 6.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Employees Cost | 0.38 | 0.25 | 0.19 | 0.14 | 0.11 |
| Depreciation | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.53 | -0.01 | 0.34 | 0.25 | 0.44 |
| Total Expenses | 7.67 | 0.25 | 0.54 | 0.40 | 0.55 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.52 | -0.25 | -0.54 | -0.40 | -0.55 |
| Other Income | 0.02 | 0.64 | 0.00 | 0.00 | 0.00 |
| P/L Before Interest, Excpt. Items & Tax | -0.50 | 0.39 | -0.54 | -0.40 | -0.55 |
| P/L Before Exceptional Items & Tax | -0.50 | 0.39 | -0.54 | -0.40 | -0.55 |
| P/L Before Tax | -0.50 | 0.39 | -0.54 | -0.40 | -0.55 |
| P/L After Tax from Ordinary Activities | -0.50 | 0.39 | -0.54 | -0.40 | -0.55 |
| Net Profit/Loss For the Period | -0.50 | 0.39 | -0.54 | -0.40 | -0.55 |
| | | | | | |
| Equity Share Capital | 23.71 | 23.71 | 10.08 | 10.08 | 4.39 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.21 | 0.21 | -0.53 | -3.94 | -1.24 |
| Diluted EPS (Rs.) | -0.21 | 0.21 | -0.53 | -3.94 | -1.24 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.21 | 0.21 | -0.53 | -3.94 | -1.24 |
| Diluted EPS (Rs.) | -0.21 | 0.21 | -0.53 | -3.94 | -1.24 |
| | | | | | |
| PBITOE Margin (%) | -7.21 | N.A | N.A | N.A | N.A |
| PBTE Margin (%) | -6.99 | N.A | N.A | N.A | N.A |
| PBT Margin (%) | -6.99 | N.A | N.A | N.A | N.A |
| PAT Margin (%) | -6.99 | N.A | N.A | N.A | N.A |
